Home/Filings/4/0001437749-22-016636
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-22-016636

CIK 0000880242other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 5:35 PM ET

Size

14.1 KB

Accession

0001437749-22-016636

Insider Transaction Report

Form 4
Period: 2022-06-30
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2022-06-30+150,0004,236,500 total
    Exercise: $0.18From: 2022-06-30Exp: 2032-06-30Common stock (150,000 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace option(s) previously issued in lieu of cash compensation to Reporting Person for services provided to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price of the Option and the current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.
  • [F2]Total reflects the expiration of an option to purchase 300,000 shares at $0.35 issued in 2012 to Reporting Person.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:35 PM ET
Size
14.1 KB